Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Q'apel Medical, Inc.
WARNING LETTER
•Q'apel Medical, Inc.•August 8, 2024

Q'apel Medical, Inc. – FDA Warning Letter, Aug 8, 2024

Record Details

An FDA inspection of Q’Apel Medical in Fremont, CA, from July 29 to August 8, 2024, revealed significant violations regarding their 072 Aspiration System (HIPPO). The device is deemed adulterated under section 501(f)(1)(B) of the Act for lacking an approved Premarket Approval (PMA) or Investigational Device Exemption (IDE). It is also misbranded under section 502(o) for failure to submit a 510(k) premarket notification. Specifically, the firm marketed a modified device with a nitinol tip capable of diameter and length changes, which significantly affects safety or effectiveness, without seeking new clearance or approval as required by 21 CFR 807.81(a)(3). Furthermore, the inspection identified that the device is adulterated under section 501(h) due to non-conformity with Quality System (QS) regulation (21 CFR Part 820). Key QS violations include inadequate documentation of design input requirements (21 CFR 820.30(c)), failure to establish and maintain design verification procedures (21 CFR 820.30(f)), inadequate design change procedures (21 CFR 820.30(i)), insufficient procedures for complaint handling (21 CFR 820.198(a)), and failure to adequately establish and maintain document control procedures (21 CFR 820.40). The firm's responses to the FDA 483 observations were largely deemed inadequate. Q’Apel Medical must cease commercial distribution of the non-compliant device and provide a comprehensive response within fifteen business days detailing corrective actions, including a timetable for systemic changes. Failure to comply may lead to regulatory actions such as seizure, injunction, civil money penalties, and impact on federal contracts and future device approvals.

Company
Q'apel Medical, Inc.
Inspection date
August 8, 2024
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Sean M. Boyd (Office Director)
  • Jim Talbot
View Company Profile

ID · 5ad007a8-5c97-4c72-8e1b-6fd29d3d9b65

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 351(h)21 CFR 82021 CFR 807.81(a)(3)21 CFR 820.30(c)21 CFR 820.30(f)

Full citation text and observation details available on the Dashboard.

Other documents for Q'apel Medical, Inc.
  • 483 - 2022-03-08March 8, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Q'apel Medical, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.